Is It Useful to Question the Recovery Behaviour of Patients with ME/CFS or Long COVID?

被引:15
作者
Vink, Mark
Vink-Niese, Friso
机构
[1] Independent Researcher, Amsterdam
[2] Independent Researcher, Osnabrück
关键词
CFS; chronic fatigue syndrome; eminence-based medicine; evidence-based medicine; insurance medicine; long COVID; ME; occupational medicine; post-infectious disease; recovery behaviour; CHRONIC-FATIGUE-SYNDROME; MODERATE EXERCISE; GENERAL-PRACTICE; THERAPY;
D O I
10.3390/healthcare10020392
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
For the last few decades, medical guidelines have recommended treating patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) with graded exercise therapy (GET) and cognitive behavioural therapy (CBT). Moreover, doctors have questioned the recovery behaviour of these patients and stimulated them to follow these treatments so that they would be able to go back to work. In this article, we reviewed trials of GET and CBT for ME/CFS that reported on work status before and after treatment to answer the question of whether doctors should continue to question the recovery behaviour of patients with ME/CFS. Our review shows that more patients are unable to work after treatment than before treatment with CBT and GET. It also highlights the fact that both treatments are unsafe for patients with ME/CFS. Therefore, questioning the recovery behaviour of patients with ME/CFS is pointless. This confirms the conclusion from the British National Institute for Health and Care Excellence (NICE), which has recently published its updated ME/CFS guideline and concluded that CBT and GET are not effective and do not lead to recovery. Studies on CBT and GET for long COVID have not yet been published. However, this review offers no support for their use in improving the recovery of patients with an ME/CFS-like illness after infection with COVID-19, nor does it lend any support to the practice of questioning the recovery behaviour of these patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] A network medicine approach to investigating ME/CFS pathogenesis in severely ill patients: a pilot study
    Hung, Li-Yuan
    Wu, Chan-Shuo
    Chang, Chia-Jung
    Li, Peng
    Hicks, Kimberly
    Dibble, Joshua J.
    Morrison, Braxton
    Smith, Chimere L.
    Davis, Ronald W.
    Xiao, Wenzhong
    FRONTIERS IN HUMAN NEUROSCIENCE, 2025, 19
  • [42] Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and COVID-19: is there a connection?
    AlMuhaissen, Suha
    Abu Libdeh, Amal
    ElKhatib, Yara
    Alshayeb, Rund
    Jaara, Areej
    Bardaweel, Sanaa K.
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (08) : 1119 - 1126
  • [43] Adolescent and Young Adult ME/CFS After Confirmed or Probable COVID-19
    Petracek, Lindsay S.
    Suskauer, Stacy J.
    Vickers, Rebecca F.
    Patel, Neel R.
    Violand, Richard L.
    Swope, Renee L.
    Rowe, Peter C.
    FRONTIERS IN MEDICINE, 2021, 8
  • [44] A comparison of health-related factors between patients diagnosed with ME/CFS and patients with a related symptom picture but no ME/CFS diagnosis: a cross-sectional exploratory study
    Bernhoff, Gabriella
    Rasmussen-Barr, Eva
    Kaell, Lina Bunketorp
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [45] Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)
    Haffke, Milan
    Freitag, Helma
    Rudolf, Gordon
    Seifert, Martina
    Doehner, Wolfram
    Scherbakov, Nadja
    Hanitsch, Leif
    Wittke, Kirsten
    Bauer, Sandra
    Konietschke, Frank
    Paul, Friedemann
    Bellmann-Strobl, Judith
    Kedor, Claudia
    Scheibenbogen, Carmen
    Sotzny, Franziska
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [46] Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis
    Krystyna Taylor
    Matthew Pearson
    Sayoni Das
    Jason Sardell
    Karolina Chocian
    Steve Gardner
    Journal of Translational Medicine, 21
  • [47] IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)
    Hannah Preßler
    Marie-Luise Machule
    Friederike Ufer
    Isabel Bünger
    Lucie Yuanting Li
    Emilie Buchholz
    Claudia Werner
    Esther Beraha
    Frank Wagner
    Matthes Metz
    Susen Burock
    Lisa Bruckert
    Christiana Franke
    Nicola Wilck
    Anne Krüger
    Alexander Reshetnik
    Kai-Uwe Eckardt
    Matthias Endres
    Harald Prüss
    Trials, 25
  • [48] IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)
    Pressler, Hannah
    Machule, Marie-Luise
    Ufer, Friederike
    Buenger, Isabel
    Li, Lucie Yuanting
    Buchholz, Emilie
    Werner, Claudia
    Beraha, Esther
    Wagner, Frank
    Metz, Matthes
    Burock, Susen
    Bruckert, Lisa
    Franke, Christiana
    Wilck, Nicola
    Krueger, Anne
    Reshetnik, Alexander
    Eckardt, Kai-Uwe
    Endres, Matthias
    Pruess, Harald
    TRIALS, 2024, 25 (01)
  • [49] Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro
    Flaskamp, Lavinia
    Roubal, Constanze
    Uddin, Steven
    Sotzny, Franziska
    Kedor, Claudia
    Bauer, Sandra
    Scheibenbogen, Carmen
    Seifert, Martina
    CELLS, 2022, 11 (15)
  • [50] Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis
    Taylor, Krystyna
    Pearson, Matthew
    Das, Sayoni
    Sardell, Jason
    Chocian, Karolina
    Gardner, Steve
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)